NCT06492577Completed
Combined Pulmonary Rehabilitation and PMR for Long-Term COVID-19 Symptoms: A RCT
Effectiveness of Combined Pulmonary Rehabilitation and Progressive Muscle Relaxation on Long-term COVID-19 Symptoms: a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 3 Dec 2024
Brief summary (registry, in English)
Our study aimed to evaluate the effectiveness of a 21-day program combining pulmonary rehabilitation (PR) with progressive muscle relaxation (PMR) in patients experiencing long-term symptoms of COVID-19. Participants with persistent symptoms will be randomly assigned to either a PR group or a PR combined with PMR group. The PR program includes aerobic exercises, strength training, and breathing exercises, while the PMR sessions involve systematic muscle tensing and relaxation techniques. We will measure outcomes such as lung function, exercise capacity, anxiety, depression, and sleep quality using validated questionnaires and clinical tests.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 61 (actual)
- First submitted
- 4 Jul 2024
- Start date
- 15 Jul 2024
- Primary completion date
- 6 Oct 2024
- Lead sponsor
- Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06492577
What you commit to
- Study type: Interventional
- Participants enrolled: 61
- From 15 Jul 2024 to the primary completion date, 6 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe comorbid conditions such as moderate to severe heart disease, severe ischemic or hemorrhagic stroke, neurodegenerative diseases, or severe acute illnesses.
- Major surgery or hospitalization for severe conditions within the past six months.
- Severe cognitive or psychiatric disorders, determined through comprehensive cognitive and psychiatric evaluations.
- Active respiratory infections or immunocompromised status.
Other
- Severe mobility impairments or chronic pain that could limit participation in rehabilitation exercises.
- High alcohol intake or substance abuse.
Who the study is looking for
- Confirmed diagnosis of COVID-19 through documented positive PCR or antibody tests.
- Persistent long-COVID-19 symptoms, specifically moderate or severe dyspnea and fatigue, lasting for at least three months post-infection.
- Adults aged between 18 and 75 years.
- Stable medical condition with no recent exacerbations or hospital admissions for other conditions in the past three months.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Spitalul de Boli Infectioase si Pneumoftiziologie Victor Babes Coordinator of this site? Confirm its status | Timișoara | Romania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.